List of insiders holdings for Disc Medicine Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Leonard Braden Michael 10% Owner | 2022-10-27 16:23:13 | 247,500 5,000,000 | 5,247,500 | Form 4 |
| Tananbaum James B. Director 10% Owner | 2021-10-06 16:15:57 | 17,245 4,840,250 | 4,857,495 | Form 4 |
| George Jean Director 10% Owner | 2021-02-16 17:23:18 | 0 4,836,106 | 4,836,106 | Form 3 |
| AI DMI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 2024-06-20 16:02:34 | 3,558,426 0 | 3,558,426 | Form 4 |
| Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 2024-01-25 16:38:29 | 1,402,186 0 | 1,402,186 | Form 13D |
| Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC 10% Owner | 2024-01-25 16:38:29 | 1,402,186 0 | 1,402,186 | Form 13D |
| Bitterman Kevin Director | 2024-06-20 20:00:05 | 0 1,149,052 | 1,149,052 | Form 4 |
| Novo Holdings A/S 10% Owner | 2023-06-28 17:22:55 | 1,090,772 0 | 1,090,772 | Form 13G |
| FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner | 2023-01-04 17:43:13 | 487,025 0 | 487,025 | Form 13D |
| LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Singapore L.P. Lightstone Singapore Associates LLC Carusi Michael A Plain Henry A JR 10% Owner | 2023-02-14 16:37:40 | 483,609 0 | 483,609 | Form 13D |
| Quisel John D Chief Executive Officer | 2024-07-10 16:15:02 | 310,276 0 | 310,276 | Form 4 |
| Uknis Marc Chief Medical Officer | 2021-04-07 16:06:30 | 277,117 0 | 277,117 | Form 4 |
| Barone Samuel B. Chief Medical Officer | 2021-04-14 16:03:03 | 255,212 0 | 255,212 | Form 4 |
| Lauder Scott Chief Technology Officer | 2021-04-07 16:02:16 | 243,996 0 | 243,996 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 2024-06-20 17:19:39 | 0 235,391 | 235,391 | Form 4 |
| Ashiya Mona Director | 2024-06-20 17:27:54 | 0 235,391 | 235,391 | Form 4 |
| Meyenburg Jason Patrick Chief Executive Officer | 2022-01-05 16:08:07 | 123,600 0 | 123,600 | Form 4 |
| Stephenson Pamela Chief Commercial Officer | 2024-02-27 17:38:25 | 91,666 0 | 91,666 | Form 4 |
| Franchi Jean M. Chief Financial Officer | 2024-02-15 20:37:53 | 91,666 0 | 91,666 | Form 4 |
| Redmond Precillia Chief People Officer | 2021-04-07 16:04:53 | 77,450 0 | 77,450 | Form 4 |
| Savage William Jacob Chief Medical Officer | 2024-11-19 18:46:25 | 76,439 0 | 76,439 | Form 4 |
| BELOFF GREGG Chief Financial Officer | 2021-02-10 17:23:21 | 66,203 0 | 66,203 | Form 3 |
| Bryce Joanne Chief Financial Officer | 2024-03-01 19:49:14 | 50,915 0 | 50,915 | Form 4 |
| Yu Jonathan Yen-Wen Chief Business Officer | 2024-03-01 19:38:18 | 45,415 0 | 45,415 | Form 4 |
| Khara Rahul General Counsel | 2024-03-01 19:39:04 | 35,085 0 | 35,085 | Form 4 |
| Dubin Daniel Director | 2020-08-11 21:35:54 | 30,000 0 | 30,000 | Form 3 |
| Carey Robert Director | 2020-08-11 21:35:15 | 30,000 0 | 30,000 | Form 3 |
| PAKIANATHAN DEEPIKA Director | 2020-08-11 21:36:24 | 30,000 0 | 30,000 | Form 3 |
| Piekos Brian CFO | 2022-06-02 19:14:01 | 17,615 0 | 17,615 | Form 4 |
| Lubner David Charles Director | 2022-03-09 18:15:52 | 17,529 0 | 17,529 | Form 4/A |
| Rhodes Jason P Director 10% Owner | 2021-10-06 16:15:39 | 17,245 0 | 17,245 | Form 4 |
| GORDON CARL L Director 10% Owner | 2021-10-06 16:15:32 | 17,245 0 | 17,245 | Form 4 |
| MacDonald Brian Richard Chief Innovation Officer | 2023-06-30 18:29:14 | 12,276 3,288 | 15,564 | Form 4 |
| Ong Tuyen Director | 2022-03-09 18:14:33 | 15,528 0 | 15,528 | Form 4/A |
| Ratcliffe Liam Director | 2024-06-14 16:15:06 | 10,000 0 | 10,000 | Form 4 |
| GEMAYEL GEORGES Director | 2024-06-14 16:15:08 | 10,000 0 | 10,000 | Form 4 |
| Chin Mark Director | 2024-06-14 16:15:05 | 10,000 0 | 10,000 | Form 4 |
| Nicholson Donald William Director | 2024-06-14 16:15:04 | 10,000 0 | 10,000 | Form 4 |
| Strapps Walter Chief Scientific Officer | 2021-05-03 16:02:18 | 9,000 0 | 9,000 | Form 4 |
| Backstrom Jay T. Director | 2023-01-03 17:05:23 | 7,000 0 | 7,000 | Form 4 |
| White William Richard Director | 2024-11-05 19:16:28 | 2,005 0 | 2,005 | Form 4 |
| Bajaj Vikram Director | 2020-08-11 21:39:58 | 0 0 | 0 | Form 3 |
| Rome Michael E Vice President | 2020-08-11 21:39:26 | 0 0 | 0 | Form 3 |
| Ryan Dennis D Chief Financial Officer | 2020-08-11 21:36:58 | 0 0 | 0 | Form 3 |